广州卫健委:境外输入病例涉及公共场所外环境采集标本呈阴性

2020-04-07 佚名 v

4月7日,在广州市第68场疫情防控新闻通气会上,广州市卫健委副主任欧阳资文表示,全市共排查高风险国家在穗人员3779人 ,境外输入病例涉及公共场所外环境采集标本均为阴性,市民无需恐慌。

4月7日,在广州市第68场疫情防控新闻通气会上,广州市卫健委副主任欧阳资文表示,全市共排查高风险国家在穗人员3779人 ,境外输入病例涉及公共场所外环境采集标本均为阴性,市民无需恐慌。

全市共排查高风险国家在穗人员3779人

欧阳资文表示,近日,广州市全面做好高风险国家在穗人员的排查管理。截至4月6日,全市共排查高风险国家在穗人员3779人,已全部进行核酸检测,并纳入健康管理。

全面排查期间,在越秀区矿泉街的入境人员中检测出5例确诊病例,均为尼日利亚籍,皆为集中医学观察期间筛查发现。疾控机构开展流行病学调查发现,上述5例确诊病例中,有4人曾在短时间内多次到越秀区矿泉街“美妙美食店”(EmmaFood)用餐。

境外输入病例涉及公共场所外环境采集标本均为阴性

疾控机构根据这条线索进行深入流行病学调查,通过对密切接触者追踪和发热门诊排查,发现近日报告的4例境外输入关联病例(越秀区3例、白云区1例);共甄别出197名密切接触者,已全部实行核酸检测、集中隔离医学观察;扩大排查出高风险场所的1680名相关人员,亦已全部采样进行核酸检测;对境外输入病例曾到过的8个餐厅、9个酒店、12个公共场所外环境采集标本571份,检测结果均为阴性。

同时,揭阳市根据广州市发出的密接人员协查通报,追查到从广州到揭阳的密接者1人及其在当地的玩伴1人,均在当地确诊,相关密切接触者也已接受集中隔离和健康管理。

广州疫情可防可控,市民无需恐慌

根据国家分区分级、精准防控的要求,广州市及时动态调整防控措施,越秀区、白云区防控风险调整为中风险,对高风险人群集聚的重点区域、场所加强管理,提高防控措施级别,对人员加强健康监测、管理。

目前,全市累计对32182名入境人员(含6321名外籍入境人员)进行集中隔离或居家隔离。疾控专家评估认为,目前广州市疫情可防可控,但是这些人群中发现零星散发病例和境外输入病例引起的传播风险仍然存在。因此,要继续保持高度警惕,不能有丝毫松懈,科学防治、精准施策。我们有信心、有能力控制疫情,为复工复产和恢复正常生活秩序提供健康安全保障,全体市民无需恐慌,但仍需加强个人防护,保持社交距离,继续积极做好疫情防控工作。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1758977, encodeId=11b61e5897733, content=<a href='/topic/show?id=39e96195411' target=_blank style='color:#2F92EE;'>#标本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61954, encryptionId=39e96195411, topicName=标本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f437392611, createdName=ms306040998833292, createdTime=Sat Sep 12 14:01:05 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022050, encodeId=96b120220509d, content=<a href='/topic/show?id=d9ff298315f' target=_blank style='color:#2F92EE;'>#公共场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29831, encryptionId=d9ff298315f, topicName=公共场所)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Jan 04 23:01:05 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949046, encodeId=b973194904658, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sun Jun 21 17:01:05 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258735, encodeId=a3a01258e355a, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Thu Apr 09 07:01:05 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1758977, encodeId=11b61e5897733, content=<a href='/topic/show?id=39e96195411' target=_blank style='color:#2F92EE;'>#标本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61954, encryptionId=39e96195411, topicName=标本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f437392611, createdName=ms306040998833292, createdTime=Sat Sep 12 14:01:05 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022050, encodeId=96b120220509d, content=<a href='/topic/show?id=d9ff298315f' target=_blank style='color:#2F92EE;'>#公共场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29831, encryptionId=d9ff298315f, topicName=公共场所)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Jan 04 23:01:05 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949046, encodeId=b973194904658, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sun Jun 21 17:01:05 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258735, encodeId=a3a01258e355a, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Thu Apr 09 07:01:05 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1758977, encodeId=11b61e5897733, content=<a href='/topic/show?id=39e96195411' target=_blank style='color:#2F92EE;'>#标本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61954, encryptionId=39e96195411, topicName=标本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f437392611, createdName=ms306040998833292, createdTime=Sat Sep 12 14:01:05 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022050, encodeId=96b120220509d, content=<a href='/topic/show?id=d9ff298315f' target=_blank style='color:#2F92EE;'>#公共场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29831, encryptionId=d9ff298315f, topicName=公共场所)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Jan 04 23:01:05 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949046, encodeId=b973194904658, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sun Jun 21 17:01:05 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258735, encodeId=a3a01258e355a, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Thu Apr 09 07:01:05 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1758977, encodeId=11b61e5897733, content=<a href='/topic/show?id=39e96195411' target=_blank style='color:#2F92EE;'>#标本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61954, encryptionId=39e96195411, topicName=标本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45f437392611, createdName=ms306040998833292, createdTime=Sat Sep 12 14:01:05 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022050, encodeId=96b120220509d, content=<a href='/topic/show?id=d9ff298315f' target=_blank style='color:#2F92EE;'>#公共场所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29831, encryptionId=d9ff298315f, topicName=公共场所)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Jan 04 23:01:05 CST 2021, time=2021-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949046, encodeId=b973194904658, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Sun Jun 21 17:01:05 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258735, encodeId=a3a01258e355a, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Thu Apr 09 07:01:05 CST 2020, time=2020-04-09, status=1, ipAttribution=)]

相关资讯

磁共振阴性额叶癫痫患者致痫灶定位研究6例

6例额叶癫痫患者,男3例,女3例,年龄4~26岁,平均14.9岁,平均病程8.7年。

J Med Virol:在HBeAg/anti-HBe血清学转换过程中,HBV基因D型儿童HBV Pre-Core的选择性突变,导致成年后HBeAg阴性慢性乙型

选择性的Pre-C突变发生在HBV复制控制不良的儿童的HBeAg/anti-HBe血清学转换时期,导致成年后HBeAg-阴性慢性-活动性肝炎

内镜图谱:幽门螺杆菌阴性胃癌内镜下特征

幽门螺杆菌(Hp)导致慢性胃炎,进而导致胃癌。在日本因为广泛的Hp根除治疗,Hp感染率逐步下降,在过去十年中,日本的胃癌死亡率以每年3%~4%的速度下降。另有研究表明,根除Hp可降低三分之一患者的异时性胃癌的发生。然而还有一些报告描述了Hp阴性胃癌(H. pylori-negative gastric cancers,HpNGC)的病例,其患病率约为0.42%~5.4%。请注意下图的A类风险人群(

驱动基因阴性晚期非小细胞肺癌治疗如何破解?

靶向治疗为驱动基因阳性非小细胞肺癌(NSCLC)患者带来福音,但临床实践中大部分患者不具有驱动基因突变。对于这部分患者,临床医生更应该关注,从诊断到治疗策略制定都应该全面而精准。肿瘤资讯采访了来自南京军区南京总医院的宋勇教授、西安交通大学第一附属医院的姚煜教授、郑州大学第一附属医院的李醒亚教授,带领大家破解驱动基因阴性患者治疗谜题。

糖水试验阴性却诊断为PNH 为啥?

50岁男性:①临床表现为贫血症状,铁剂治疗效果不佳;②实验室检查:渐进性全血细胞减少;维生素B12偏低;溶血全套均阴性;尿胆原++,尿潜血 +,尿蛋白 +;TBIL高;骨髓红细胞系增生明显活跃,易见嗜多色性红细胞;巨核细胞量及粒细胞系均偏低;③未查网织红细胞,但其溶血是存在的,后查抗核抗体谱均阴性,溶血存在,全血细胞少,尿Rous试验为阳性。所患何病

Int J Cardiol:D-二聚体阴性对急性主动脉夹层早期评估的影响!

由此可见,该研究发现高血小板计数和低扩张分数是导致D-二聚体阴性结果的独立因素。即使夹层长度很短,对于一些D-二聚体阴性的病人,急诊手术也是必要的。医生应该认识到血浆D-二聚体阴性结果的患者不能排除致命性AAD的情况。